Anna Greka
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Anna Greka is the founder of Goldfinch Bio, Inc., founded in 2016.
Current jobs include Director at Ovid Therapeutics, Inc. starting in 2026 and Professor at Harvard Medical School since 2012.
Education history includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-15 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| OVID THERAPEUTICS INC. | Direktör/Styrelseledamot | 2026-06-15 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån